檢索結果 - P. Andrew Futreal

Refine Results
  1. 1
    Understanding the target

    Understanding the target 由 Michael R. Stratton, P. Andrew Futreal

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Somatic Mutations in Human Cancer: Insights from Resequencing the Protein Kinase Gene Family

    Somatic Mutations in Human Cancer: Insights from Resequencing the Protein Kinase Gene Family 由 P. Andrew Futreal, Richard Wooster, Michael R. Stratton

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Breast cancer genome heterogeneity: a challenge to personalised medicine?

    Breast cancer genome heterogeneity: a challenge to personalised medicine? 由 Charles Swanton, Rebecca A. Burrell, P. Andrew Futreal

    出版 2011
    獲取全文 獲取全文
    Editorial
    加到收藏夾
    Saved in:
  4. 4
    An Alu polymorphism intragenic to the TP53 gene

    An Alu polymorphism intragenic to the TP53 gene 由 P. Andrew Futreal, J. Carl Barrett, Roger W. Wiseman

    出版 1991
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    The cancer genome

    The cancer genome 由 Michael R. Stratton, Peter J. Campbell, P. Andrew Futreal

    出版 2009
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Emerging patterns of somatic mutations in cancer

    Emerging patterns of somatic mutations in cancer 由 Ian R. Watson, Koichi Takahashi, P. Andrew Futreal, Lynda Chin

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    A survey of RNA editing in human brain

    A survey of RNA editing in human brain 由 Matthew J. Blow, P. Andrew Futreal, Richard Wooster, Michael R. Stratton

    出版 2004
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Genetic screens using the piggyBac transposon

    Genetic screens using the piggyBac transposon 由 Su Kit Chew, Roland Rad, P. Andrew Futreal, Allan Bradley, Pentao Liu

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer

    Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer 由 Chris Greenman, Richard Wooster, P. Andrew Futreal, Michael R. Stratton, Douglas F. Easton

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association

    Prediction of biomarkers and therapeutic combinations for anti-PD-1 immunotherapy using the global gene network association 由 Chia-Chin Wu, Yanru Wang, J. Andrew Livingston, Jianhua Zhang, P. Andrew Futreal

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Cancer and genomics

    Cancer and genomics 由 P. Andrew Futreal, Arek Kasprzyk, Ewan Birney, James C. Mullikin, Richard Wooster, Michael R. Stratton

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data

    MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data 由 Yu Fan, Xi Liu, Daniel Hughes, Jianjun Zhang, Jianhua Zhang, P. Andrew Futreal, David A. Wheeler, Wenyi Wang

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    A census of human cancer genes

    A census of human cancer genes 由 P. Andrew Futreal, Lachlan Coin, Mhairi Marshall, Thomas A. Down, Tim Hubbard, Richard Wooster, Nazneen Rahman, Michael R. Stratton

    出版 2004
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma

    Amplification and Overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in Medulloblastoma 由 Lu Yuan, Sarra L. Ryan, David J. Elliott, Graham R. Bignell, P. Andrew Futreal, David W. Ellison, Simon Bailey, Steven C. Clifford

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    RNA editing of human microRNAs.

    RNA editing of human microRNAs. 由 Matthew J. Blow, Russell J Grocock, Stijn van Dongen, Anton J. Enright, Ed Dicks, P. Andrew Futreal, Richard Wooster, Michael R. Stratton

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)

    Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN) 由 Hannah C. Beird, Maliha Khan, Rui Wang, Mansour Alfayez, Tianyu Cai, Li Zhao, Joseph D. Khoury, P. Andrew Futreal, Marina Konopleva, Naveen Pemmaraju

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    The Catalogue of Somatic Mutations in Cancer (COSMIC)

    The Catalogue of Somatic Mutations in Cancer (COSMIC) 由 Simon Forbes, Gurpreet Bhamra, Sally Bamford, Elisabeth Dawson, Chai Yin Kok, Jody Clements, Andrew Menzies, Jon W. Teague, P. Andrew Futreal, Michael R. Stratton

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Whole genome DNA copy number changes identified by high density oligonucleotide arrays

    Whole genome DNA copy number changes identified by high density oligonucleotide arrays 由 Jing Huang, Wen Wei, Jane Zhang, Guoying Liu, Graham R. Bignell, Michael R. Stratton, P. Andrew Futreal, Richard Wooster, Keith Jones, Michael H. Shapero

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer

    Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer 由 Christoph Kahlert, Sónia A. Melo, Alexei Protopopov, Jiabin Tang, Sahil Seth, Moritz Koch, Jianhua Zhang, Juergen Weitz, Lynda Chin, P. Andrew Futreal, Raghu Kalluri

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

    LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition 由 Claire Mahoney, Bhudipa Choudhury, Helen Davies, Sarah Edkins, Chris Greenman, Gijs van Haaften, Tatiana Mironenko, Thomas Santarius, Claire Stevens, Michael R. Stratton, P. Andrew Futreal

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: